GO
Loading...

Eli Lilly and Co

More

  • Final Glance: Pharmaceuticals companies Thursday, 26 Feb 2015 | 6:02 PM ET

    Baxter International Inc. fell$. 19 or. 3 percent, to $68.67. Bristol-Myers Squibb Co. rose$. 24 or. 4 percent, to $61.46. Eli Lilly& Co. fell$. 33 or. 5 percent, to $70.03.

  • Midday Glance: Pharmaceuticals companies Thursday, 26 Feb 2015 | 1:19 PM ET

    Baxter International Inc. fell$. 03 or percent, to $68.83. Bristol-Myers Squibb Co. rose$. 27 or. 4 percent, to $61.49. Eli Lilly& Co. fell$. 57 or. 8 percent, to $69.79.

  • Early Glance: Pharmaceuticals companies Thursday, 26 Feb 2015 | 10:35 AM ET

    Baxter International Inc. fell$. 11 or. 2 percent, to $68.75. Bristol-Myers Squibb Co. fell$. 42 or. 7 percent, to $60.80. Eli Lilly& Co. fell$. 70 or 1.0 percent, to $69.66.

  • Feb 26- Sanofi's new Toujeo diabetes drug has won U.S. regulatory approval but with wording on its label that analysts say could make marketing difficult. Sanofi shares were 1 percent lower at 88.20 euros by 1029 GMT. Sanofi bought some time with a patent infringement lawsuit filed last year against Eli Lilly and Co to keep a cheaper Lantus generic off the market...

  • Midday Glance: Pharmaceuticals companies Wednesday, 25 Feb 2015 | 1:18 PM ET

    Baxter International Inc. fell$. 16 or. 2 percent, to $68.90. Bristol-Myers Squibb Co. fell$. 16 or. 3 percent, to $61.30. Eli Lilly& Co. fell$. 24 or. 3 percent, to $70.66.

  • Early Glance: Pharmaceuticals companies Wednesday, 25 Feb 2015 | 11:23 AM ET

    Baxter International Inc. fell$. 09 or. 1 percent, to $68.97. Bristol-Myers Squibb Co. fell$. 40 or. 7 percent, to $61.05. Johnson& Johnson fell$. 40 or. 4 percent, to $100.30.

  • Final Glance: Pharmaceuticals companies Tuesday, 24 Feb 2015 | 6:02 PM ET

    Baxter International Inc. rose$. 42 or. 6 percent, to $69.06. Bristol-Myers Squibb Co. rose$. 16 or. 3 percent, to $61.45. Eli Lilly& Co. fell$. 19 or. 3 percent, to $70.90.

  • Midday Glance: Pharmaceuticals companies Tuesday, 24 Feb 2015 | 1:17 PM ET

    Baxter International Inc. rose$. 27 or. 4 percent, to $68.91. Bristol-Myers Squibb Co. fell$. 10 or. 2 percent, to $61.19. Eli Lilly& Co. fell$. 26 or. 4 percent, to $70.83.

  • Early Glance: Pharmaceuticals companies Tuesday, 24 Feb 2015 | 11:24 AM ET

    Baxter International Inc. rose$. 22 or. 3 percent, to $68.86. Bristol-Myers Squibb Co. fell$. 54 or. 9 percent, to $60.75. Eli Lilly& Co. fell$. 15 or. 2 percent, to $70.94.

  • Final Glance: Pharmaceuticals companies Monday, 23 Feb 2015 | 6:04 PM ET

    Baxter International Inc. rose$. 74 or 1.1 percent, to $68.64. Bristol-Myers Squibb Co. rose$. 77 or 1.3 percent, to $61.29. Eli Lilly& Co. fell$. 79 or 1.1 percent, to $71.09.

  • Midday Glance: Pharmaceuticals companies Monday, 23 Feb 2015 | 1:20 PM ET

    Baxter International Inc. rose$. 72 or 1.1 percent, to $68.62. Bristol-Myers Squibb Co. rose$. 65 or 1.1 percent, to $61.17. Eli Lilly& Co. fell$. 99 or 1.4 percent, to $70.89.

  • Feb 23- Eli Lilly and Co said it would postpone by at least two years the marketing application for its once-daily diabetes treatment to evaluate liver concerns, a delay some analysts said could doom the experimental drug. In the meantime, Lilly continues to develop a cheaper, rival "biosimilar" form of Sanofi's blockbuster once-daily Lantus insulin that...

  • Early Glance: Pharmaceuticals companies Monday, 23 Feb 2015 | 10:40 AM ET

    Baxter International Inc. rose$. 63 or. 9 percent, to $68.53. Bristol-Myers Squibb Co. rose$. 17 or. 3 percent, to $60.69. Eli Lilly& Co. fell$. 65 or. 9 percent, to $71.23.

  • Feb 23- Eli Lilly and Co said it would delay its application to market its once-daily diabetes treatment, basal insulin peglispro, beyond the current quarter. The delay stems from a need to generate additional data to evaluate any potential effects on liver fat related to the treatment in late-stage trials, Lilly said. The company said it could not determine the...

  • Final Glance: Pharmaceuticals companies Friday, 20 Feb 2015 | 6:00 PM ET

    Baxter International Inc. rose$. 48 or. 7 percent, to $67.90. Bristol-Myers Squibb Co. rose$. 97 or 1.6 percent, to $60.52. Eli Lilly& Co. rose$. 76 or 1.1 percent, to $71.88.

  • Midday Glance: Pharmaceuticals companies Friday, 20 Feb 2015 | 1:36 PM ET

    Baxter International Inc. fell$. 75 or 1.1 percent, to $66.68. Bristol-Myers Squibb Co. rose$. 48 or. 8 percent, to $60.03. Eli Lilly& Co. rose$. 15 or. 2 percent, to $71.27.

  • Early Glance: Pharmaceuticals companies Friday, 20 Feb 2015 | 10:50 AM ET

    Baxter International Inc. fell $1.29 or 1.9 percent, to $66.13. Bristol-Myers Squibb Co. rose$. 10 or. 2 percent, to $59.65. Eli Lilly& Co. fell$. 35 or. 5 percent, to $70.77.

  • Final Glance: Pharmaceuticals companies Thursday, 19 Feb 2015 | 6:03 PM ET

    Baxter International Inc. fell$. 98 or 1.4 percent, to $67.42. Bristol-Myers Squibb Co. fell$. 46 or. 8 percent, to $59.55. Eli Lilly& Co. rose$. 11 or. 2 percent, to $71.12.

  • Midday Glance: Pharmaceuticals companies Thursday, 19 Feb 2015 | 1:28 PM ET

    Baxter International Inc. fell$. 91 or 1.3 percent, to $67.49. Bristol-Myers Squibb Co. fell$. 96 or 1.6 percent, to $59.06. Eli Lilly& Co. fell$. 14 or. 2 percent, to $70.87.

  • Early Glance: Pharmaceuticals companies Thursday, 19 Feb 2015 | 10:51 AM ET

    Baxter International Inc. fell$. 87 or 1.3 percent, to $67.53. Bristol-Myers Squibb Co. fell$. 34 or. 6 percent, to $59.67. Eli Lilly& Co. rose$. 24 or. 3 percent, to $71.25.